GeoVax Labs, Inc. (GOVX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 09:40AM EDT. Market open.
| Previous close | 0.8301 |
| Open | 0.8326 |
| Bid | 0.8159 x 1100 |
| Ask | 0.0000 x 800 |
| Day's range | 0.8130 - 0.8485 |
| 52-week range | 0.5500 - 7.5000 |
| Volume | |
| Avg. volume | 10,227,691 |
| Market cap | 10.226M |
| Beta (5Y monthly) | 1.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.9700 |
| Earnings date | 09 Aug 2022 - 15 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.00 |
- Simply Wall St.
GeoVax Labs (NASDAQ:GOVX) Will Have To Spend Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Business Wire
Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows It Produced Robust Antibodies and T Cells Against SARS-CoV-2
LOS ANGELES & ATLANTA, March 10, 2022--COVID-19 investigational vaccine developed by City of Hope produced neutralizing antibodies and T cells with no major side effects in Phase 1 trial.
© 2022 Yahoo. All rights reserved.
